Authors:
PLATONOV AE
SHIPULIN GA
VERSHININA IV
DANKERT J
VANDEWINKEL JGJ
KUIJPER EJ
Citation: Ae. Platonov et al., ASSOCIATION OF HUMAN FC-GAMMA-RIIA (CD32) POLYMORPHISM WITH SUSCEPTIBILITY TO AND SEVERITY OF MENINGOCOCCAL DISEASE, Clinical infectious diseases, 27(4), 1998, pp. 746-750
Citation: G. Vidarsson et Jgj. Vandewinkel, RECEPTOR AND COMPLEMENT RECEPTOR-MEDIATED PHAGOCYTOSIS IN HOST-DEFENSE, Current opinion in infectious diseases, 11(3), 1998, pp. 271-278
Citation: Wl. Vanderpol et Jgj. Vandewinkel, IGG RECEPTOR POLYMORPHISMS - RISK-FACTORS FOR DISEASE, Immunogenetics (New York), 48(3), 1998, pp. 222-232
Authors:
DEVRIES IJM
WALKER C
VANREIJSEN FC
DUBOIS GR
KNOL EF
BRUIJNZEELKOOMEN CAFM
VANDEWINKEL JGJ
BRUIJNZEEL PLB
Citation: Ijm. Devries et al., INDUCTION AND FUNCTION OF FC-GAMMA-RI ON HUMAN EOSINOPHILS - LIGATIONOF FC-GAMMA-RI ON EOSINOPHILS RESULTS IN ACCESSORY SIGNALS FOR CD3-INDUCED T-LYMPHOCYTE PROLIFERATION, Journal of allergy and clinical immunology, 101(1), 1998, pp. 612-612
Authors:
PAPAPANOU PN
NEIDERUD AM
PAPADIMITRIOU A
SANDROS J
MADIANOS PN
VANDEWINKEL JGJ
DAHLEN G
Citation: Pn. Papapanou et al., A MULTI-FACTORIAL MODEL FOR ASSESSING THE RISK FOR PERIODONTAL-DISEASE, Journal of dental research, 77, 1998, pp. 124-124
Citation: Mj. Vanvugt et al., FC-GAMMA-RIA-GAMMA-CHAIN COMPLEXES TRIGGER ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY (ADCC) IN CD5(-CELL() B)MACROPHAGE-IIA1.6 CELLS/, Clinical and experimental immunology, 113(3), 1998, pp. 415-422
Authors:
PLATONOV AE
KUIJPER EJ
VERSHININA IV
SHIPULIN GA
WESTERDAAL N
FIJEN CAP
VANDEWINKEL JGJ
Citation: Ae. Platonov et al., MENINGOCOCCAL DISEASE AND POLYMORPHISM OF FC-GAMMA-RIIA (CD32) IN LATE COMPLEMENT COMPONENT-DEFICIENT INDIVIDUALS, Clinical and experimental immunology, 111(1), 1998, pp. 97-101
Authors:
WURFLEIN D
DECHANT M
STOCKMEYER B
TUTT AL
HU PS
REPP R
KALDEN JR
VANDEWINKEL JGJ
EPSTEIN AL
VALERIUS T
GLENNIE M
GRAMATZKI M
Citation: D. Wurflein et al., EVALUATING ANTIBODIES FOR THEIR CAPACITY TO INDUCE CELL-MEDIATED LYSIS OF MALIGNANT B-CELLS, Cancer research, 58(14), 1998, pp. 3051-3058
Authors:
STOCKMEYER B
DECHANT M
REPP R
VALERIUS T
DEO Y
GRAZIANO R
KALDEN JR
GLENNIE M
VANDEWINKEL JGJ
GRAMATZKI W
Citation: B. Stockmeyer et al., IMMUNOTHERAPY OF B-CELL MALIGNANCIES VIA [FC-ALPHA-RIXCD20] DIRECTED BISPECIFIC ANTIBODIES, British Journal of Haematology, 102(1), 1998, pp. 85-85
Authors:
CARLSSON LE
SANTOSO S
BAURICHTER G
KROLL H
PAPENBERG S
EICHLER P
WESTERDAAL NAC
KIEFEL V
VANDEWINKEL JGJ
GREINACHER A
Citation: Le. Carlsson et al., HEPARIN-INDUCED THROMBOCYTOPENIA - NEW INSIGHTS INTO THE IMPACT OF THE FC-GAMMA-RIIA-R-H131 POLYMORPHISM, Blood, 92(5), 1998, pp. 1526-1531
Authors:
MANGER K
REPP R
SPRIEWALD BM
RASCU A
GEIGER A
WASSMUTH R
WESTERDAAL NAC
WENTZ B
MANGER B
KALDEN JR
VANDEWINKEL JGJ
Citation: K. Manger et al., FC-GAMMA RECEPTOR IIA POLYMORPHISM IN CAUCASIAN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS - ASSOCIATION WITH CLINICAL SYMPTOMS, Arthritis and rheumatism, 41(7), 1998, pp. 1181-1189
Authors:
VALERIUS T
ELSASSER D
REPP R
VANDEWINKEL JGJ
GRAMATZKI M
GLENNIE M
Citation: T. Valerius et al., HLA CLASS-II ANTIBODIES RECRUIT G-CSF ACTIVATED NEUTROPHILS FOR TREATMENT OF B-CELL MALIGNANCIES, Leukemia & lymphoma, 26(3-4), 1997, pp. 261
Citation: Iafm. Heijnen et al., LYSIS OF MURINE B-LYMPHOMA-CELLS BY TRANSGENIC PHAGOCYTES VIA A HUMANFC-GAMMA-RI X MURINE MHC CLASS-II BISPECIFIC ANTIBODY, Cancer immunology and immunotherapy, 45(3-4), 1997, pp. 166-170
Authors:
VANOJIK HH
REPP R
GROENEWEGEN G
VALERIUS T
VANDEWINKEL JGJ
Citation: Hh. Vanojik et al., CLINICAL-EVALUATION OF THE BISPECIFIC ANTIBODY MDX-H210 (ANTI-FC-GAMMA-RI-X-ANTI-HER-2 NEU) IN COMBINATION WITH GRANULOCYTE-COLONY-STIMULATING FACTOR (FILGRASTIM) FOR TREATMENT OF ADVANCED BREAST-CANCER/, Cancer immunology and immunotherapy, 45(3-4), 1997, pp. 207-209
Authors:
STOCKMEYER B
VALERIUS T
REPP R
DEO Y
VANSPIEK A
KALDEN JR
VANDEWINKEL JGJ
GRAMATZKI M
Citation: B. Stockmeyer et al., FC-ALPHA-RI (CD89) AS A NOVEL CYTOTOXIC TRIGGER MOLECULE FOR BISPECIFIC ANTIBODIES, Experimental hematology, 25(8), 1997, pp. 560-560
Authors:
POOLE A
GIBBINS JM
TURNER M
VANVUGT MJ
VANDEWINKEL JGJ
SAITO T
TYBULEWICZ VLJ
WATSON SP
Citation: A. Poole et al., THE FC RECEPTOR GAMMA-CHAIN AND THE TYROSINE KINASE SYK ARE ESSENTIALFOR ACTIVATION OF MOUSE PLATELETS BY COLLAGEN, EMBO journal, 16(9), 1997, pp. 2333-2341
Authors:
GRATAMA JW
VANDERLINDEN R
VANDERHOLT B
BOLHUIS RLH
VANDEWINKEL JGJ
Citation: Jw. Gratama et al., ANALYSIS OF FACTORS CONTRIBUTING TO THE FORMATION OF MONONUCLEAR CELLAGGREGATES (ESCAPEES) IN FLOW CYTOMETRIC IMMUNOPHENOTYPING, Cytometry, 29(3), 1997, pp. 250-260
Authors:
DEO YM
GRAZIANO RF
REPP R
VANDEWINKEL JGJ
Citation: Ym. Deo et al., CLINICAL-SIGNIFICANCE OF IGG FC-RECEPTORS AND FC-GAMMA-R-DIRECTED IMMUNOTHERAPIES, Immunology today, 18(3), 1997, pp. 127-135
Authors:
HEIJNEN IAFM
RIJKS LJM
SCHIEL A
STOCKMEYER B
VANOJIK HH
DECHANT M
VALERIUS T
KELER T
TUTT AL
GLENNIE MJ
VANROYEN EA
CAPEL PJA
VANDEWINKEL JGJ
Citation: Iafm. Heijnen et al., GENERATION OF HER-2 NEU-SPECIFIC CYTOTOXIC NEUTROPHILS IN-VIVO - EFFICIENT ARMING OF NEUTROPHILS BY COMBINED ADMINISTRATION OF GRANULOCYTE-COLONY-STIMULATING FACTOR AND FC-GAMMA RECEPTOR-I BISPECIFIC ANTIBODIES/, The Journal of immunology, 159(11), 1997, pp. 5629-5639
Authors:
KOBAYASHI T
WESTERDAAL NAC
MIYAZAKI A
VANDERPOL WL
SUZUKI T
YOSHIE H
VANDEWINKEL JGJ
HARA K
Citation: T. Kobayashi et al., RELEVANCE OF IMMUNOGLOBULIN-G FC RECEPTOR POLYMORPHISM TO RECURRENCE OF ADULT PERIODONTITIS IN JAPANESE PATIENTS, Infection and immunity, 65(9), 1997, pp. 3556-3560